Atherosclerotic cardiovascular disease screening in adults: American College of Preventive Medicine position statement on preventive practice

American Journal of Preventive Medicine

Volumn 40, Issue 3, 2011, Pages 381.e1-381.e10

  Lim, Lionel S ^a   Haq, Nowreen ^a   Mahmood, Shamail ^a   Hoeksema, Laura ^a   Surricchio, Michele ^b   Abraham Katz, Ronit Ben ^b   Bergeisen, Gershon ^b   Compton, Michael T ^b   Guillory, V James ^b   Hammer, Douglas I ^b  

^a GRIFFIN HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ABDOMINAL AORTA ANEURYSM; ANKLE BRACHIAL INDEX; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CAROTID ARTERY OBSTRUCTION; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; ELECTROCARDIOGRAM; EXERCISE TEST; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRACTICE GUIDELINE; PREVENTIVE MEDICINE; RISK ASSESSMENT; SCREENING TEST; SMOKING;

EID: 79951795503     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amepre.2010.11.021     Document Type: Article

References (55)

1. American Heart Association. Heart disease and stroke statistics 2009 update. Dallas TX: American Heart Association, 2009.
2. Berger JS, Jordan CO, Lloyd-Jones D, Blumenthal RS. Screening for cardiovascular risk in asymptomatic patients. J Am Coll Cardiol 2010;55(12):1169-77.
3. Pignone M, Fowler-Brown A, Pletcher M, Tice J. Screening for asymptomatic coronary artery disease: a systematic review for the U.S. Preventive Services Task Force. Rockville MD: Agency for Healthcare Research and Quality, 2003.
4. U.S. Preventive Services Task Force. Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009;151(7):474-82.
5. Helfand M, Buckley DI, Freeman M, et al. Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Ann Intern Med 2009;151(7):496-507.
6. Helfand M, Buckley D, Fleming C, et al. Screening for intermediate risk factors for coronary heart disease: systematic evidence synthesis. Rockville MD: Agency for Healthcare Research and Quality, 2009. Report No.: Evidence synthesis No. 73. AHRQ Publication No. 09-05137-EF-1.
7. Humphrey LL, Fu R, Rogers K, Freeman M, Helfand M. Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis. Mayo Clin Proc 2008;83(11):1203-12.
8. Buckley DI, Fu R, Freeman M, Rogers K, Helfand M. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med 2009;151(7):483-95.
9. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359(21):2195-207.
10. U.S. Food and Drug Administration. Questions and answers for healthcare professionals: CRESTOR and the JUPITER Trial. www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm199891.htm.
11. Greenland P, Bonow RO, Brundage BH, et al.ACCF/AHA2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). Circulation 2007;115(3):402-26.
12. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the CDC and the American Heart Association. Circulation 2003;107(3):499-511.
13. NIH. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III): executive summary 2001. Bethesda MD: NIH.
14. U.S. Preventive Services Task Force. Screening for coronary heart disease: recommendation statement. Ann Intern Med 2004;140(7):569-72.
15. Naghavi M, Falk E, Hecht HS, et al. From vulnerable plaque to vulnerable patient, Part III: executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol 2006;98(2A):2H-15H.
16. CDC. Fast stats: deaths and mortality. www.cdc.gov/nchs/fastats/deaths. htm.
17. Taylor TN, Davis PH, Torner JC, Holmes J, Meyer JW, Jacobson MF. Lifetime cost of stroke in the U.S. Stroke 1996;27(9):1459-66.
18. O'Leary DH, Anderson KM, Wolf PA, Evans JC, Poehlman HW. Cholesterol and carotid atherosclerosis in older persons: the Framingham study. Ann Epidemiol 1992;2(1-2):147-53.
19. Chambers BR, Donnan GA. Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Syst Rev 2005;(4):CD001923.
20. Wolff T, Guirguis-Blake J, Miller T, Gillespie M, Harris R. Screening for carotid artery stenosis: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2007;147(12):860-70. (Pubitemid 351664428)
21. Nagaki T, Sato K, Yoshida T, Yoshimoto Y. Benefit of carotid endarterectomy for symptomatic and asymptomatic severe carotid artery stenosis: a Markov model based on data from randomized controlled trials. Clinical article. J Neurosurg 2009;111(5):970-7.
22. Henriksson M, Lundgren F, Carlsson P. Cost-effectiveness of endarterectomy in patients with asymptomatic carotid artery stenosis. Br J Surg 2008;95(6):714-20.
23. U.S. Preventive Services Task Force. Screening for carotid artery stenosis: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2007;147(12):854-9.
24. Creager MA, White CJ, Hiatt WR, et al. Atherosclerotic Peripheral Vascular Disease Symposium II: executive summary. Circulation 2008;118(25):2811-25.
25. Chaturvedi S, Bruno A, Feasby T, et al. Carotid endarterectomy - an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2005;65(6):794-801. (Pubitemid 41362117)
26. Society for Vascular Surgery. SVS position statement on vascular screenings. www.vascularweb.org/patients/screenings/SVS-Position-Statement-on- Vascular-Screenings.html.
27. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115(5):e69-171.
28. Margolis J, Barron JJ, Grochulski WD. Health care resources and costs for treating peripheral artery disease in a managed care population: results from analysis of administrative claims data. J Manag Care Pharm 2005;11(9):727-34.
29. Allison MA, Ho E, Denenberg JO, et al. Ethnic-specific prevalence of peripheral arterial disease in the U.S. Am J Prev Med 2007;32(4):328-33. (Pubitemid 46441734)
30. Newman AB, Siscovick DS, Manolio TA, et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 1993;88(3):837-45. (Pubitemid 23263998)
31. McDermott MM, Greenland P, Liu K, et al. The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med 2002;136(12):873-83. (Pubitemid 34625699)
32. McDermott MM, Liu K, Greenland P, et al. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA 2004;292(4):453-61. (Pubitemid 38988954)
33. Aboyans V, Criqui MH. Can we improve cardiovascular risk prediction beyond risk equations in the physician's office? J Clin Epidemiol 2006;59(6):547-58.
34. Fowkes FG, Murray GD, Butcher I, et al. Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008;300(2):197-208. (Pubitemid 351969304)
35. Halperin JL, Fuster V. Meeting the challenge of peripheral arterial disease. Arch Intern Med 2003;163(8):877-8. (Pubitemid 36519733)
36. McDermott MM. Ankle brachial index as a predictor of outcomes in peripheral arterial disease. J Lab Clin Med 1999;133(1):33-40. (Pubitemid 29032414)
37. Mohler ER 3rd, Treat-Jacobson D, Reilly MP, et al. Utility and barriers to performance of the ankle-brachial index in primary care practice. Vasc Med 2004;9(4):253-60. (Pubitemid 40202240)
38. Ouriel K, McDonnell AE, Metz CE, Zarins CK. Critical evaluation of stress testing in the diagnosis of peripheral vascular disease. Surgery 1982;91(6):686-93. (Pubitemid 13083950)
39. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/ Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006;113(11):e463-654.
40. U.S. Preventive Services Task Force. Screening for peripheral arterial disease: recommendation statement. Am Fam Physician 2006;73(3):497-500.
41. Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pogach LM. Preventive foot care in diabetes. Diabetes Care 2004;27(1S):S63-4.
42. Sacks D, BakalCW,Beatty PT, et al. Position statement on the use of the ankle brachial index in the evaluation of patients with peripheral vascular disease. A consensus statement developed by the Standards Division of the Society of Interventional Radiology. J Vasc Interv Radiol 2003;14(9 Pt 2):S389.
43. Anderson RN. Deaths: leading causes for 2000. Natl Vital Stat Rep 2002;50(16):1-85.
44. Ehlers L, Sorensen J, Jensen LG, Bech M, Kjolby M. Is population screening for abdominal aortic aneurysm cost-effective? BMC Cardiovasc Disord 2008;8:32.
45. Lederle FA. Management of small abdominal aortic aneurysms. Ann Intern Med 1990;113(10):731-2. (Pubitemid 20369659)
46. Johnston KW, Rutherford RB, Tilson MD, Shah DM, Hollier L, Stanley JC. Suggested standards for reporting on arterial aneurysms. Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg 1991;13(3):452-8.
47. Verloes A, Sakalihasan N, Koulischer L, Limet R. Aneurysms of the abdominal aorta: familial and genetic aspects in three hundred thirteen pedigrees. J Vasc Surg 1995;21(4):646-55.
48. Lederle FA, Johnson GR, Wilson SE. Abdominal aortic aneurysm in women. J Vasc Surg 2001;34(1):122-6. (Pubitemid 33660699)
49. Fleming C, Whitlock EP, Beil TL, Lederle FA. Screening for abdominal aortic aneurysm: a best-evidence systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2005;142(3):203-11. (Pubitemid 40189113)
50. Cosford PA, Leng GC. Screening for abdominal aortic aneurysm. Cochrane Database Syst Rev 2007;(2):CD002945.
51. Lederle FA, Wilson SE, Johnson GR, et al. Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 2002;346(19):1437-44. (Pubitemid 34755711)
52. Kim LG, P Scott RA, Ashton HA, Thompson SG; Multicentre Aneurysm Screening Study Group. A sustained mortality benefit from screening for abdominal aortic aneurysm. Ann Intern Med 2007;146(10):699-706.
53. U.S. Preventive Services Task Force. Screening for abdominal aortic aneurysm: recommendation statement. Ann Intern Med 2005;142(3):198-202.
54. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease) - summary of recommendations. J Vasc Interv Radiol 2006;17(9):1383-97; quiz 1398.
55. Kent KC, Zwolak RM, Jaff MR, et al. Screening for abdominal aortic aneurysm: a consensus statement. J Vasc Surg 2004;39(1):267-9. (Pubitemid 38056189)